Inventor · disambiguated record
Andreas Supersaxo
Also filed as: SUPERSAXO ANDREAS · SUPERSAXO ANDREAS WERNER
11 granted patents·1 pending application·299 citations·filing 1993–2016
90Inventor score
Files withHOFFMANN LA ROCHE3CIBA SC HOLDING AG2VESIFACT AG2ROCHE CONSUMER HEALTH WORLDWID1SINIQ GMBH1
Top patents by PatentIndex Score
12 records- 0192US5470582AControlled delivery of pharmaceuticals from preformed porous polymeric microparticlesSYNTEX INC·Filed 1993·Granted Nov 28, 1995·152 cites·15 claims
- 0288US7871642B2Use of nanodispersions in pharmaceutical end formulationsCIBA SC HOLDING AG·Filed 2006·Granted Jan 18, 2011·12 cites·26 claims
- 0381US7381423B2Use of nanodispersions in cosmetic end formulationsCIBA SC HOLDING AG·Filed 2005·Granted Jun 3, 2008·2 cites·22 claims
- 0481US5376646ATopical preparations containing the salt of a cholanic acid and a lipidHOFFMANN LA ROCHE·Filed 1993·Granted Dec 27, 1994·72 cites·5 claims
- 0573US8158134B1Microemulsion preconcentrate, microemulsion and use thereofSUPERSAXO ANDREAS·Filed 2000·Granted Apr 17, 2012·10 cites·22 claims
- 0670US6420394B1Topically applied pharmaceutical formulationROCHE CONSUMER HEALTH WORLDWID·Filed 1998·Granted Jul 16, 2002·35 cites·7 claims
- 0765US7008638B2Use of nanodispersions in cosmetic end formulationsVESIFACT AG·Filed 2001·Granted Mar 7, 2006·3 cites·11 claims
- 0846US5759827AAcylated oligopeptides for transfecting cellsHOFFMANN LA ROCHE·Filed 1996·Granted Jun 2, 1998·6 cites·24 claims
- 0944US2004152612A1Coenzyme q10 containing microemulsion preconcentrates and microemulsionsFiled 2002·Application pending·0 cites
- 1038US7081253B2Use of nanodispersions in pharmaceutical end formulationsVESIFACT AG·Filed 1999·Granted Jul 25, 2006·3 cites·9 claims
- 1137US6030602APeptide conjugates for transfecting cellsHOFFMANN LA ROCHE·Filed 1997·Granted Feb 29, 2000·4 cites·12 claims
- 1228US10695460B2Composition for covering and protecting scarsSINIQ GMBH·Filed 2016·Granted Jun 30, 2020·0 cites·28 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →